NCT00621218View on ClinicalTrials.gov

A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

April 30, 2008

Study Completion Date

December 31, 2008

Conditions
Rosacea
Interventions
DRUG

tretinoin gel 0.05%

Apply tretinoin gel, 0.05% topically once or twice daily to female subjects with rosacea

DRUG

vehicle

Apply Atralin Gel vehicle topically once or twice daily to female subjects with rosacea.

Trial Locations (1)

19428

Product Investigations, Inc., Conshohocken

Sponsors
All Listed Sponsors
lead

Coria Laboratories, Ltd.

INDUSTRY